Hedge Fund - Foresite Capital
Cymabay Therapeutics Inc. (CBAY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2022 - Q3 (2022-09-30) | $5,746,000 | 15.16% | 1,641,804 | $3.59 |
| 2 | 2022 - Q2 (2022-06-30) | $4,843,000 | 17.56% | 1,641,804 | $2.39 |
| 3 | 2022 - Q1 (2022-03-31) | $5,106,000 | 15.55% | 1,641,804 | $3.15 |
| 4 | 2021 - Q4 (2021-12-31) | $5,549,000 | 14.04% | 1,641,804 | $3.80 |
| 5 | 2021 - Q3 (2021-09-30) | $5,993,000 | 8.31% | 1,641,804 | $3.94 |
| 6 | 2021 - Q2 (2021-06-30) | $7,158,000 | 7.58% | 1,641,804 | $4.43 |
| 7 | 2021 - Q1 (2021-03-31) | $7,454,000 | 6.54% | 1,641,804 | $5.38 |
| 8 | 2020 - Q4 (2020-12-31) | $9,424,000 | 10.95% | 1,641,804 | $7.57 |
| 9 | 2020 - Q3 (2020-09-30) | $11,887,000 | 8.85% | 1,641,804 | $5.35 |
| 10 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $1.68 |
| 11 | 2019 - Q4 (2019-12-31) | $2,949,000 | 1.65% | 1,504,710 | $3.76 |
| 12 | 2019 - Q3 (2019-09-30) | $7,721,000 | 2.94% | 1,508,091 | $6.05 |
| 13 | 2019 - Q2 (2019-06-30) | $11,364,000 | 3.72% | 1,587,101 | $11.32 |
| 14 | 2019 - Q1 (2019-03-31) | $21,077,000 | 5.48% | 1,587,101 | $10.64 |
| 15 | 2018 - Q4 (2018-12-31) | $12,490,000 | 4.1% | 1,587,101 | $9.52 |
| 16 | 2018 - Q3 (2018-09-30) | $17,307,000 | 3.81% | 1,562,040 | $12.42 |
| 17 | 2018 - Q2 (2018-06-30) | $20,963,000 | 4.51% | 1,562,040 | $12.51 |
| 18 | 2018 - Q1 (2018-03-31) | $20,291,000 | 4.42% | 1,562,040 | $12.42 |
| 19 | 2017 - Q4 (2017-12-31) | $5,520,000 | 1.54% | 600,000 | $8.55 |
| 20 | 2017 - Q3 (2017-09-30) | $4,836,000 | 1.33% | 600,000 | $6.76 |
The displayed share prices are average quarterly stock market prices.